Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetratricopeptide repeat domain 41, pseudogene (TTC41P) is a human pseudogene annotated in major genomic databases and does not encode a functional protein product[9][3]. While pseudogenes can sometimes participate in gene regulation—such as acting as microRNA sponges or influencing RNA stability—there are no published functional, mechanistic, or disease associations specific to TTC41P to date[2][4]. It is sometimes referenced with aliases such as GNN and GNNP, and its sequence shows homology to tetratricopeptide repeat proteins but lacks protein-coding capacity[1][9]. Thus, TTC41P is not considered a conventional molecular target for drug discovery or therapeutic intervention[9][1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat domain 41, pseudogene (TTC41P).